EMD 53998 acts as Ca2+-sensitizer and phosphodiesterase III-inhibitor in human myocardium
- 1 January 1995
- journal article
- research article
- Published by Springer Nature in Basic Research in Cardiology
- Vol. 90 (5) , 365-371
- https://doi.org/10.1007/bf00788497
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart.Circulation, 1993
- Effects of calcium and EMD-53998 on oxygen consumption in isolated canine hearts.Circulation, 1992
- Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure.Circulation, 1992
- Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathyAmerican Heart Journal, 1992
- Calcium-sensitizing inotropic agents in the treatment of heart failure: A critical viewCardiovascular Drugs and Therapy, 1991
- Antagonism of novel inotropic agents at A1 adenosine receptors and m-cholinoceptors in human myocardiumNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1990
- Evidence against spare or uncoupled β-adrenoceptors in the human heartAmerican Heart Journal, 1990
- A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart FailureNew England Journal of Medicine, 1989
- Interaction of DPI 201–106 with Cardiac GlycosidesJournal of Cardiovascular Pharmacology, 1989
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982